Chang MW - Search Results

1

The Fungal Mycobiome and Its Interaction with Gut Bacteria in the Host.

Sam QH, Chang MW, Chai LY. Sam QH, et al. Among authors: chang mw. Int J Mol Sci. 2017 Feb 4;18(2):330. doi: 10.3390/ijms18020330. Int J Mol Sci. 2017. PMID: 28165395 Free PMC article. Review.

2

Immunomodulation as Therapy for Fungal Infection: Are We Closer?

Sam QH, Yew WS, Seneviratne CJ, Chang MW, Chai LYA. Sam QH, et al. Among authors: chang mw. Front Microbiol. 2018 Jul 25;9:1612. doi: 10.3389/fmicb.2018.01612. eCollection 2018. Front Microbiol. 2018. PMID: 30090091 Free PMC article. Review.

3

Engineering commensal bacteria to rewire host-microbiome interactions.

Hwang IY, Chang MW. Hwang IY, et al. Among authors: chang mw. Curr Opin Biotechnol. 2020 Apr;62:116-122. doi: 10.1016/j.copbio.2019.09.007. Epub 2019 Oct 22. Curr Opin Biotechnol. 2020. PMID: 31654857 Review.

4

The Divergent Immunomodulatory Effects of Short Chain Fatty Acids and Medium Chain Fatty Acids.

Sam QH, Ling H, Yew WS, Tan Z, Ravikumar S, Chang MW, Chai LYA. Sam QH, et al. Among authors: chang mw. Int J Mol Sci. 2021 Jun 16;22(12):6453. doi: 10.3390/ijms22126453. Int J Mol Sci. 2021. PMID: 34208638 Free PMC article.

5

Dominant Negative TRAF3 Variant With Recurrent Mycobacterium abscessus Infection and Bronchiectasis.

Liew MF, Lim HF, Liang MC, Lim I, Tan Z, Tan RYM, Sam QH, Soe WM, Tay SH, Xu S, Chang MW, Foo R, Soong TW, Ravikumar S, Chai LYA. Liew MF, et al. Among authors: chang mw. Open Forum Infect Dis. 2022 Aug 3;9(8):ofac379. doi: 10.1093/ofid/ofac379. eCollection 2022 Aug. Open Forum Infect Dis. 2022. PMID: 36004314 Free PMC article.

6

Engineering of a probiotic yeast for the production and secretion of medium-chain fatty acids antagonistic to an opportunistic pathogen Candida albicans.

Ling H, Liu R, Sam QH, Shen H, Chai LYA, Chang MW. Ling H, et al. Among authors: chang mw. Front Bioeng Biotechnol. 2023 Feb 27;11:1090501. doi: 10.3389/fbioe.2023.1090501. eCollection 2023. Front Bioeng Biotechnol. 2023. PMID: 36923462 Free PMC article.

7

Reprogrammable microbial cell-based therapeutics against antibiotic-resistant bacteria.

Hwang IY, Koh E, Kim HR, Yew WS, Chang MW. Hwang IY, et al. Among authors: chang mw. Drug Resist Updat. 2016 Jul;27:59-71. doi: 10.1016/j.drup.2016.06.002. Epub 2016 Jun 22. Drug Resist Updat. 2016. PMID: 27449598 Review.

8

Engineering microbes for targeted strikes against human pathogens.

Hwang IY, Lee HL, Huang JG, Lim YY, Yew WS, Lee YS, Chang MW. Hwang IY, et al. Among authors: chang mw. Cell Mol Life Sci. 2018 Aug;75(15):2719-2733. doi: 10.1007/s00018-018-2827-7. Epub 2018 May 7. Cell Mol Life Sci. 2018. PMID: 29736607 Review.

9

Targeted Approaches for In Situ Gut Microbiome Manipulation.

Lee HL, Shen H, Hwang IY, Ling H, Yew WS, Lee YS, Chang MW. Lee HL, et al. Among authors: chang mw. Genes (Basel). 2018 Jul 12;9(7):351. doi: 10.3390/genes9070351. Genes (Basel). 2018. PMID: 30002345 Free PMC article. Review.

10

Meta-Omics- and Metabolic Modeling-Assisted Deciphering of Human Microbiota Metabolism.

Sieow BF, Nurminen TJ, Ling H, Chang MW. Sieow BF, et al. Among authors: chang mw. Biotechnol J. 2019 Sep;14(9):e1800445. doi: 10.1002/biot.201800445. Epub 2019 Jul 8. Biotechnol J. 2019. PMID: 31144773 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

397 results

Search Page